128 related articles for article (PubMed ID: 28446188)
1. Phosphorylation by mTORC1 stablizes Skp2 and regulates its oncogenic function in gastric cancer.
Geng Q; Liu J; Gong Z; Chen S; Chen S; Li X; Lu Y; Zhu X; Lin HK; Xu D
Mol Cancer; 2017 Apr; 16(1):83. PubMed ID: 28446188
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting the role of Skp2 suppresses cell proliferation and tumorigenesis of human gastric cancer cells via the upregulation of p27kip1.
Wen Y; Wang K; Yang K
Mol Med Rep; 2016 Oct; 14(4):3917-24. PubMed ID: 27572672
[TBL] [Abstract][Full Text] [Related]
3. Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation.
Hibdon ES; Razumilava N; Keeley TM; Wong G; Solanki S; Shah YM; Samuelson LC
Neoplasia; 2019 Jul; 21(7):702-712. PubMed ID: 31129492
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition.
Kim ST; Kim SY; Klempner SJ; Yoon J; Kim N; Ahn S; Bang H; Kim KM; Park W; Park SH; Park JO; Park YS; Lim HY; Lee SH; Park K; Kang WK; Lee J
Ann Oncol; 2017 Mar; 28(3):547-554. PubMed ID: 28028034
[TBL] [Abstract][Full Text] [Related]
5. PPP2R2D, a regulatory subunit of protein phosphatase 2A, promotes gastric cancer growth and metastasis via mechanistic target of rapamycin activation.
Yu S; Li L; Wu Q; Dou N; Li Y; Gao Y
Int J Oncol; 2018 Jun; 52(6):2011-2020. PubMed ID: 29568966
[TBL] [Abstract][Full Text] [Related]
6. Thioridazine reverses trastuzumab resistance in gastric cancer by inhibiting S-phase kinase associated protein 2-mediated aerobic glycolysis.
Yang ZY; Zhao YW; Xue JR; Guo R; Zhao Z; Liu HD; Ren ZG; Shi M
World J Gastroenterol; 2023 Dec; 29(45):5974-5987. PubMed ID: 38130998
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of mTOR signalling potentiates the effects of trichostatin A in human gastric cancer cell lines by promoting histone acetylation.
Sun DF; Zhang YJ; Tian XQ; Chen YX; Fang JY
Cell Biol Int; 2014 Jan; 38(1):50-63. PubMed ID: 24030871
[TBL] [Abstract][Full Text] [Related]
8. Targeting TLK2 inhibits the progression of gastric cancer by reprogramming amino acid metabolism through the mTOR/ASNS axis.
Wang M; Li J; Yang X; Yan Q; Wang H; Xu X; Lu Y; Li D; Wang Y; Sun R; Zhang S; Zhang Y; Zhang Z; Meng F; Li Y
Cancer Gene Ther; 2023 Nov; 30(11):1485-1497. PubMed ID: 37542132
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor 1 promotes growth of gastric cancer by inhibiting foxo1 nuclear retention.
Li S; Lei X; Zhang J; Yang H; Liu J; Xu C
Tumour Biol; 2015 Jun; 36(6):4519-23. PubMed ID: 25596089
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-508-5p suppresses metastasis in human gastric cancer by targeting S-phase kinase‑associated protein 2.
Duan X; Bai J; Wei J; Li Z; Liu X; Xu G
Mol Med Rep; 2017 Aug; 16(2):2163-2171. PubMed ID: 28627698
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-1285 Regulates 17β-Estradiol-Inhibited Immature Boar Sertoli Cell Proliferation via Adenosine Monophosphate-Activated Protein Kinase Activation.
Jiao ZJ; Yi W; Rong YW; Kee JD; Zhong WX
Endocrinology; 2015 Nov; 156(11):4059-70. PubMed ID: 26287402
[TBL] [Abstract][Full Text] [Related]
12. mTOR is involved in 17β-estradiol-induced, cultured immature boar Sertoli cell proliferation via regulating the expression of SKP2, CCND1, and CCNE1.
Yang WR; Wang Y; Wang Y; Zhang JJ; Zhang JH; Lu C; Wang XZ
Mol Reprod Dev; 2015 Apr; 82(4):305-14. PubMed ID: 25739982
[TBL] [Abstract][Full Text] [Related]
13. The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway.
Li Y; Gu J; Lu H
Dig Dis Sci; 2017 Dec; 62(12):3426-3437. PubMed ID: 29098549
[TBL] [Abstract][Full Text] [Related]
14. The inhibition of histone deacetylase 8 suppresses proliferation and inhibits apoptosis in gastric adenocarcinoma.
Song S; Wang Y; Xu P; Yang R; Ma Z; Liang S; Zhang G
Int J Oncol; 2015 Nov; 47(5):1819-28. PubMed ID: 26412386
[TBL] [Abstract][Full Text] [Related]
15. miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis.
Huang T; Kang W; Zhang B; Wu F; Dong Y; Tong JH; Yang W; Zhou Y; Zhang L; Cheng AS; Yu J; To KF
Mol Cancer; 2016 Jan; 15():9. PubMed ID: 26801246
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.
Cao GD; Xu XY; Zhang JW; Chen B; Xiong MM
PLoS One; 2016; 11(12):e0168085. PubMed ID: 28005970
[TBL] [Abstract][Full Text] [Related]
17. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.
Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N
BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559
[TBL] [Abstract][Full Text] [Related]
18. Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin.
Yu X; Wang R; Zhang Y; Zhou L; Wang W; Liu H; Li W
Oncogene; 2019 Dec; 38(50):7457-7472. PubMed ID: 31435020
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of SKP2 and phospho-MAPK/ERK1/2 and decreased expression of p27 during tumor progression of cervical neoplasms.
Chen TP; Chen CM; Chang HW; Wang JS; Chang WC; Hsu SI; Cho CL
Gynecol Oncol; 2007 Mar; 104(3):516-23. PubMed ID: 17079005
[TBL] [Abstract][Full Text] [Related]
20. Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model.
Li X; Yokoyama NN; Zhang S; Ding L; Liu HM; Lilly MB; Mercola D; Zi X
Oncotarget; 2015 Dec; 6(39):41809-24. PubMed ID: 26497688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]